Hearing Rehabilitation Implementing a Transcutaneous Bone Conduction Device: Single-Center Experience.
Publication/Presentation Date
6-1-2021
Abstract
Bone conduction implants based on percutaneous abutment acoustic transmission have been implemented in patients with satisfactory outcomes. However, adverse soft tissue outcomes present a limitation. Transcutaneous bone conduction devices (t-BCDs) are an alternative that may mitigate these complications. A retrospective review was performed of patients who underwent implantation of a t-BCD from 2013 to 2017. Surgical outcomes were reviewed including wound complications, frequency of device use, patient concerns regarding the device, and reported patient satisfaction. A total of 37 patients were implanted with the bone-anchored hearing aids, BAHA Attract (Cochlear™ Baha® Implant System). Average follow-up time was 271.8 days. Postoperatively, 7 (18.9%) patients complained of soft tissue changes or issues with wound healing. Twelve (32.4%) patients requested adjustment of their devices. The t-BCD is an excellent option for hearing rehabilitation. Overall, the complication rate is low, patient satisfaction is high, and successful conversion from a percutaneous device is possible with minimal risk.
Volume
100
Issue
3_suppl
First Page
199
Last Page
199
ISSN
1942-7522
Published In/Presented At
Shokri, T., Czarnecki, B., Baker, A., & Isildak, H. (2021). Hearing Rehabilitation Implementing a Transcutaneous Bone Conduction Device: Single-Center Experience. Ear, nose, & throat journal, 100(3_suppl), 199S–203S. https://doi.org/10.1177/0145561319870481
Disciplines
Medicine and Health Sciences
PubMedID
31565979
Department(s)
Department of Surgery
Document Type
Article